Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients
Launched by KHYBER TEACHING HOSPITAL · Mar 16, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal opacity, vitreous hemorrhage, proliferative diabetic retinopathy, already received anti-VEGF injections, history of pan-retinal photocoagulation for proliferative diabetic retinopathy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with center involving diabetic macular edema on optical coherence tomography
- Exclusion Criteria:
- • Raised intraocular pressure
- • History of glaucoma
- • Corneal opacity
- • Vitreous hemorrhage
- • Proliferative diabetic retinopathy
- • Anti-VEGF injections in last 3 months
- • History of pan-retinal photocoagulation
- • Contraindications for anti-VEGF
About Khyber Teaching Hospital
Khyber Teaching Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Peshawar, Pakistan, the hospital serves as a pivotal center for medical education and training, providing comprehensive healthcare services to diverse populations. With a commitment to improving patient outcomes, Khyber Teaching Hospital engages in rigorous clinical research that adheres to the highest ethical standards, fostering collaboration among healthcare professionals, researchers, and academic institutions. The hospital aims to contribute significantly to medical science by exploring new treatments and therapies that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Khyber Pakhtunkhwa, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported